Giannis Mountzios/X
Apr 14, 2025, 01:50
Giannis Mountzios: Tarlatamab Improves Overall Survival in Advanced SCLC
Giannis Mountzios, Director of 4th Oncology Department and Clinical Trials Unit at Henry Dunant Hospital Center, shared a post on X:
“It’s official. Tarlatamab improves overall survival over SoC chemotherapy in pre-treated patients with advanced SCLC. A major breakthrough for a devastating disease after decades of failed trials.
Stay tuned for full data coming soon.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 9, 2025, 04:15
Jun 9, 2025, 04:06
Jun 9, 2025, 03:59
Jun 9, 2025, 03:26
Jun 9, 2025, 03:08
Jun 9, 2025, 02:00
Jun 8, 2025, 17:03